Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06517225 · ClinicalTrials.gov registry record · Phase 2

Visual-acoustic Intervention With Service Delivery In-person and Via Telepractice Trial

A Phase 2 study of Speech Sound Disorder, sponsored by New York University.

Recruiting
Registry status
Phase 2
Development phase
76
Enrollment target
3
Study locations

NCT06517225 is a Phase 2 study of Speech Sound Disorder that is actively recruiting participants, run by New York University. The registered enrollment target is 76 participants, below the 84-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (10% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06517225, a Phase 2 study of Speech Sound Disorder, is actively recruiting participants, sponsored by New York University.

RECRUITING
Registry status
Phase 2
Development phase
76 participants
Enrollment target
3
Study locations

Study Summary

Children with speech sound disorder show diminished intelligibility in spoken communication and may thus be perceived as less capable than peers, with negative consequences for both socioemotional and socioeconomic outcomes. New technologies have the potential to transform interventions for speech sound disorder, but there is a lack of rigorous evidence to substantiate this promise. This research will meet a public health need by systematically evaluating the efficacy of visual-acoustic biofeedback intervention delivered in-person versus via telepractice. The objective of this study is to test the hypothesis that treatment incorporating visual-acoustic biofeedback can be delivered via telepractice without a significant loss of efficacy. Participants will be randomly assigned to receive identical treatment either via online telepractice or in the laboratory setting. The same software for visual-acoustic biofeedback, staRt, will be used in both conditions. Participants' progress in treatment will be evaluated based on blinded listeners' perceptual ratings of probes produced before and after treatment. Pre and post treatment evaluations will be carried out in person for all participants.

Conditions Studied

Interventions

  • BEHAVIORAL Visual-acoustic biofeedback

Study Locations (3)

New York

  • New York University - New York
  • Syracuse University - Syracuse

New Jersey

  • Montclair State University - Bloomfield

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2024-07-01
Est. Completion 2028-12-31
Phase Phase 2

Sponsor

New York University

83 total trials

What the Registry Record Tells You About NCT06517225

The ClinicalTrials.gov registry entry for NCT06517225 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 84-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (10% lower). The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Speech Sound Disorder appearing as the primary indexed condition, and to 1 intervention - of which Visual-acoustic biofeedback is the first listed.

NCT06517225 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.

Frequently Asked Questions

What is clinical trial NCT06517225 about?

NCT06517225 is a clinical study titled "Visual-acoustic Intervention With Service Delivery In-person and Via Telepractice Trial". Children with speech sound disorder show diminished intelligibility in spoken communication and may thus be perceived as less capable than peers, with negative consequences for both socioemotional and socioeconomic outcomes. New technologies have the potential to transform interventions for speech s...

What is the current status of trial NCT06517225?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 76 participants. The study started on 2024-07-01. Estimated completion is 2028-12-31.

What conditions does trial NCT06517225 study?

This clinical trial studies the following conditions: Speech Sound Disorder.

What interventions are being tested in trial NCT06517225?

The interventions under investigation include: Visual-acoustic biofeedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT06517225?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06517225 being conducted?

This trial has 3 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Speech Sound Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.